| Richard M Walters, OD | |
|
231 Windermere Blvd, Alexandria, LA 71303 | |
| (318) 487-2020 | |
| (318) 445-7745 |
| Full Name | Richard M Walters |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 44 Years |
| Location | 231 Windermere Blvd, Alexandria, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881655082 | NPI | - | NPPES |
| 1991201 | Medicaid | LA | |
| P00169994 | Other | TRAVELERS MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 876062T (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alexandria Eye And Laser Center, Llc | 4789641010 | 22 |
News Archive
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).
In an Australian first, new research from Griffith's Australian Institute for Suicide Research and Prevention aims to tackle myths about mental health among miners.
Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Federal regulators late Friday proposed cutting payments to private Medicare plans by 1.9 percent after recent lower health care spending growth. Insurers worry the cut could be much deeper than that after health law fees and other payment changes take effect, however, and say another cut could affect benefits for seniors.
Non-invasive diagnostic imaging can rule out coronary artery disease (CAD) in about 50% of women with atypical chest pain who are at relatively low risk for CAD, while exposing them to only a modest dose of radiation.
› Verified 3 days ago
| Provider Name | Alexandria Eye And Laser Center, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538120985 PECOS PAC ID: 4789641010 Enrollment ID: O20041217000427 |
News Archive
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).
In an Australian first, new research from Griffith's Australian Institute for Suicide Research and Prevention aims to tackle myths about mental health among miners.
Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Federal regulators late Friday proposed cutting payments to private Medicare plans by 1.9 percent after recent lower health care spending growth. Insurers worry the cut could be much deeper than that after health law fees and other payment changes take effect, however, and say another cut could affect benefits for seniors.
Non-invasive diagnostic imaging can rule out coronary artery disease (CAD) in about 50% of women with atypical chest pain who are at relatively low risk for CAD, while exposing them to only a modest dose of radiation.
› Verified 3 days ago
| Provider Name | Christus Health Central Louisiana |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497895130 PECOS PAC ID: 4688570955 Enrollment ID: O20070615000135 |
News Archive
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).
In an Australian first, new research from Griffith's Australian Institute for Suicide Research and Prevention aims to tackle myths about mental health among miners.
Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Federal regulators late Friday proposed cutting payments to private Medicare plans by 1.9 percent after recent lower health care spending growth. Insurers worry the cut could be much deeper than that after health law fees and other payment changes take effect, however, and say another cut could affect benefits for seniors.
Non-invasive diagnostic imaging can rule out coronary artery disease (CAD) in about 50% of women with atypical chest pain who are at relatively low risk for CAD, while exposing them to only a modest dose of radiation.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard M Walters, OD 231 Windermere Blvd, Alexandria, LA 71303-3538 Ph: (318) 487-2020 | Richard M Walters, OD 231 Windermere Blvd, Alexandria, LA 71303 Ph: (318) 487-2020 |
News Archive
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).
In an Australian first, new research from Griffith's Australian Institute for Suicide Research and Prevention aims to tackle myths about mental health among miners.
Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Federal regulators late Friday proposed cutting payments to private Medicare plans by 1.9 percent after recent lower health care spending growth. Insurers worry the cut could be much deeper than that after health law fees and other payment changes take effect, however, and say another cut could affect benefits for seniors.
Non-invasive diagnostic imaging can rule out coronary artery disease (CAD) in about 50% of women with atypical chest pain who are at relatively low risk for CAD, while exposing them to only a modest dose of radiation.
› Verified 3 days ago
Dr. Toni Coates Harvey, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 2148 N Mall Dr, Alexandria, LA 71301 Phone: 318-442-0243 Fax: 318-442-2406 | |
Christina Rene Zamora, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 231 Windermere Blvd, Alexandria, LA 71303 Phone: 318-487-2020 Fax: 318-445-7745 | |
Dr. William C Risinger Jr., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3908 Parliament Dr, Alexandria, LA 71303 Phone: 318-445-5319 | |
Hunter Peterson, OD Optometrist Medicare: Medicare Enrolled Practice Location: 231 Windermere Blvd, Alexandria, LA 71303 Phone: 318-487-2020 | |
Lacy B Shaw, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5615-b Jackson St Ext, Alexandria, LA 71303 Phone: 318-442-7787 Fax: 318-443-1654 | |
Dr. Phillip Leo Carney Jr., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4300 Parliament Dr, Alexandria, LA 71303 Phone: 318-448-0221 Fax: 318-448-1829 | |
Anthony James Barbiero, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 231 Windermere Blvd, Alexandria, LA 71303 Phone: 318-487-2020 |